Clinical Roundup Imfinzi-based regimen reduced the risk of death in early gastric cancer vs. chemotherapy alone October 24, 2025Vol.51 No.39
Clinical Roundup Tecvayli + Darzalex Faspro improve PFS and OS vs. standard-of-care October 24, 2025Vol.51 No.39
Clinical Roundup GammaTile delivers superior tumor control vs. standard-of-care for newly diagnosed operable brain metastases October 24, 2025Vol.51 No.39
Clinical Roundup Enzalutamide drug combination cuts risk of death in advanced prostate cancer, Cedars-Sinai-led study shows October 24, 2025Vol.51 No.39
Clinical Roundup Tukysa improves HER2+ breast cancer, phase III trial shows October 17, 2025Vol.51 No.38
Clinical Roundup Enhertu demonstrates improvement in invasive DFS in HER2+ breast cancer after neoadjuvant therapy October 17, 2025Vol.51 No.38
Clinical Roundup Telemedicine consults lead to changes in treatment in half of cases, study finds October 17, 2025Vol.51 No.38
Clinical Roundup Mayo tests radiopharmaceutical theranostic for HCC in first-in-human trial October 17, 2025Vol.51 No.38
Clinical Roundup UCSD researchers engineer novel antibody that triggers anti-tumor response October 17, 2025Vol.51 No.38
